Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL   12:21:49 PM EDT
2.37
+1.30 (+121.50%)
Earnings Announcements

Avadel Pharmaceuticals Provides Corporate Update And Reports First Quarter 2022 Financial Results

Published: 05/09/2022 13:46 GMT
Avadel Pharmaceuticals plc - ADR (AVDL) - Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.45.
Net Loss for Quarter Ended March 31, 2022, Was $0.45 per Share.
Q1 Earnings per Share View $-0.43 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.